List of Tables
Table 1. Peritoneal Cancer Treatment Market Trends
Table 2. Peritoneal Cancer Treatment Market Drivers & Opportunity
Table 3. Peritoneal Cancer Treatment Market Challenges
Table 4. Peritoneal Cancer Treatment Market Restraints
Table 5. Global Peritoneal Cancer Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Peritoneal Cancer Treatment Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Peritoneal Cancer Treatment Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Peritoneal Cancer Treatment Product Type
Table 9. Key Companies Time to Begin Mass Production of Peritoneal Cancer Treatment
Table 10. Global Peritoneal Cancer Treatment Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Cancer Treatment as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Peritoneal Cancer Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Peritoneal Cancer Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Peritoneal Cancer Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Peritoneal Cancer Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Peritoneal Cancer Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Peritoneal Cancer Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Peritoneal Cancer Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Peritoneal Cancer Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Peritoneal Cancer Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Peritoneal Cancer Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Peritoneal Cancer Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Peritoneal Cancer Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Peritoneal Cancer Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Peritoneal Cancer Treatment Sales Value by Region (2019-2024) & (%)
Table 27. Global Peritoneal Cancer Treatment Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Peritoneal Cancer Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Peritoneal Cancer Treatment Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Peritoneal Cancer Treatment Sales Value, (2025-2030) & (US$ Million)
Table 31. Combat Medical Basic Information List
Table 32. Combat Medical Description and Business Overview
Table 33. Combat Medical Peritoneal Cancer Treatment Products, Services and Solutions
Table 34. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of Combat Medical (2019-2024)
Table 35. Combat Medical Recent Developments
Table 36. GSK Basic Information List
Table 37. GSK Description and Business Overview
Table 38. GSK Peritoneal Cancer Treatment Products, Services and Solutions
Table 39. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of GSK (2019-2024)
Table 40. GSK Recent Developments
Table 41. AstraZeneca Basic Information List
Table 42. AstraZeneca Description and Business Overview
Table 43. AstraZeneca Peritoneal Cancer Treatment Products, Services and Solutions
Table 44. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of AstraZeneca (2019-2024)
Table 45. AstraZeneca Recent Developments
Table 46. Oncolytics Biotech Basic Information List
Table 47. Oncolytics Biotech Description and Business Overview
Table 48. Oncolytics Biotech Peritoneal Cancer Treatment Products, Services and Solutions
Table 49. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of Oncolytics Biotech (2019-2024)
Table 50. Oncolytics Biotech Recent Developments
Table 51. Rubraca Basic Information List
Table 52. Rubraca Description and Business Overview
Table 53. Rubraca Peritoneal Cancer Treatment Products, Services and Solutions
Table 54. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of Rubraca (2019-2024)
Table 55. Rubraca Recent Developments
Table 56. ImmunoGen Basic Information List
Table 57. ImmunoGen Description and Business Overview
Table 58. ImmunoGen Peritoneal Cancer Treatment Products, Services and Solutions
Table 59. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of ImmunoGen (2019-2024)
Table 60. ImmunoGen Recent Developments
Table 61. OncoNano Basic Information List
Table 62. OncoNano Description and Business Overview
Table 63. OncoNano Peritoneal Cancer Treatment Products, Services and Solutions
Table 64. Revenue (US$ Million) in Peritoneal Cancer Treatment Business of OncoNano (2019-2024)
Table 65. OncoNano Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Peritoneal Cancer Treatment Downstream Customers
Table 69. Peritoneal Cancer Treatment Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Peritoneal Cancer Treatment Product Picture
Figure 2. Global Peritoneal Cancer Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Peritoneal Cancer Treatment Report Years Considered
Figure 5. Global Peritoneal Cancer Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Peritoneal Cancer Treatment Revenue in 2023
Figure 7. Peritoneal Cancer Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Surgery Picture
Figure 9. Chemotherapy Picture
Figure 10. Targeted Therapy Picture
Figure 11. Immunotherapy Picture
Figure 12. Radiation Therapy Picture
Figure 13. Others Picture
Figure 14. Global Peritoneal Cancer Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Peritoneal Cancer Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 16. Product Picture of Primary Peritoneal Cancer
Figure 17. Product Picture of Secondary Peritoneal Cancer
Figure 18. Global Peritoneal Cancer Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Peritoneal Cancer Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Peritoneal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Peritoneal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Peritoneal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Peritoneal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Peritoneal Cancer Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Peritoneal Cancer Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Peritoneal Cancer Treatment Sales Value (%), (2019-2030)
Figure 31. United States Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 37. China Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 39. China Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 49. India Peritoneal Cancer Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Peritoneal Cancer Treatment Sales Value by Type (%), 2023 VS 2030
Figure 51. India Peritoneal Cancer Treatment Sales Value by Application (%), 2023 VS 2030
Figure 52. Peritoneal Cancer Treatment Industrial Chain
Figure 53. Peritoneal Cancer Treatment Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
